The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

NCT06220630 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-01-24

No results posted yet for this study

Summary

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:

* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.

Researchers will investigate the features, survival associated factors and other relevant factors of this population.

Conditions

Interventions

OTHER

Breast cancer

Male patients who were microscopically diagnosed as primary breast cancer.

Sponsors & Collaborators

  • Beijing Medical Award Foundation

    collaborator UNKNOWN
  • The Affiliated Cancer Hospital of Xinjiang Medical University

    collaborator UNKNOWN
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • The Third Affiliated Hospital of Kunming Medical University

    collaborator UNKNOWN
  • Sun Yat-sen University

    collaborator OTHER
  • The Affiliated Cancer Hospital of Zhengzhou University

    collaborator UNKNOWN
  • The Third Hospital of Nanchang City

    collaborator UNKNOWN
  • Beijing 302 Hospital

    collaborator OTHER
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • First People's Hospital of Foshan

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Jiangmen Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital, Guangzhou Medical University

    collaborator UNKNOWN
  • The First Affiliated Hospital, Zhejiang University

    collaborator UNKNOWN
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Affiliated Sanming First Hospital of Fujian Medical University

    collaborator UNKNOWN
  • Jieyang People's Hospital

    collaborator OTHER
  • National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital

    collaborator UNKNOWN
  • Shantou Central Hospital

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Lianjiang Pepole's Hospital, Lianjiang

    collaborator UNKNOWN
  • Guangdong Women and Children Hospital

    collaborator OTHER
  • Zhanjiang Central Hospital

    collaborator UNKNOWN
  • Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine

    collaborator UNKNOWN
  • First Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Ying Lin, MD, PhD · 1st affiliated hospital of Sun Yat-sen university

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2025-08-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220630 on ClinicalTrials.gov